Tisztelt Olvasóink!
Ezúton szeretnénk figyelmükbe ajánlani a HS Talks - Biomedical & Life Sciences Collection legújabb online szemináriumait.
Az adatbázis a következő témájú szemináriumokkal bővült a koronavírushoz kapcsolódóan: Immunological memory, CD4 T cell subsets, Cytokines, Lymphocyte homing, PET, drug delivery carriers, HIV, COVAC1, SARS-CoV-2.
Immunological memory
Prof. David Gray University of Edinburgh, UK
Self-tolerance
Prof. Herman Waldmann University of Oxford, UK
CD4 T cell subsets
Dr. Brigitta Stockinger Associate Research Director, The Francis Crick Institute, UK
Tolerance and autoimmunity
Emeritus Prof. Anne Cooke University of Cambridge, UK
Cytokines
Prof. Iain McInnes University of Glasgow, UK
The role of immunoglobulin superfamily domains in interactions of immune cells
Prof. Neil Barclay University of Oxford, UK
Therapeutic antibodies
Dr. Geoffrey Hale Chief Executive Officer of mAbsolve Ltd., UK
Lymphocyte homing: getting lymphocytes to the right place at the right time
Prof. Ann Ager Cardiff University, UK
Antigen recognition in the immune system
Prof. Herman Waldmann University of Oxford, UK
Molecular brain imaging (PET) in diseases with dementia
Prof. Karl Herholz University of Manchester, UK
Food-borne trematodes
Prof. Russell Stothard Liverpool School of Tropical Medicine, UK
Inorganic porous drug delivery carriers
Prof. Jessica Rosenholm Åbo Akademi University, Finland
Management of feline chronic kidney disease
Dr. Jessica M. Quimby The Ohio State University, USA
Combating the HIV epidemic
Prof. William Blattner University of Maryland, Baltimore, USA, USA
Potential long-term health effects of a SARS-CoV-2 infection
Prof. Danny Altmann Imperial College London, UK
Interferon-α2b as a therapy for COVID-19
Prof. Eleanor N. Fish University of Toronto, Canada
Imperial College London's saRNA Vaccine - COVAC1
Dr. Katrina Pollock Imperial College London, UK
The neurological symptoms of COVID-19
Dr. Michael Zandi University College London, UK
Interferon-α2b as a therapy for COVID-19
Prof. Eleanor N. Fish University of Toronto, Canada
Imperial College London's saRNA Vaccine - COVAC1
Dr. Katrina Pollock Imperial College London, UK
Potential long-term health effects of a SARS-CoV-2 infection
Prof. Danny Altmann Imperial College London, UK
The neurological symptoms of COVID-19
Dr. Michael Zandi University College London, UK
The type I interferon system and viruses
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA
Rheumatic diseases and COVID-19
Dr. Zachary Wallace Massachusetts General Hospital and Harvard Medical School, USA
Challenges of accelerated vaccine development
Dr. Jakub Simon Director of Clinical Research, Vaccines, Merck Research Laboratories, USA
The cardiovascular complications of SARS-CoV-2 infection
Prof. Srihari Naidu New York Medical College, USA
Human challenge trials for vaccines against COVID-19
Prof. Peter Smith London School of Hygiene & Tropical Medicine, UK
Risk of re-emergence of COVID-19 after exit from lockdown
Dr. Leonardo Lopez Barcelona Institute for Global Health, Spain
INFβ therapy for COVID-19: the new SNG001 drug
Prof. Stephen Holgate University of Southampton, UK
Remdesivir COVID-19 clinical trial
Prof. Mahesh Parmar University College London, UK
Translating microbiome research to clinics: trends, directions and challenges
Prof. Raj Eri University of Tasmania, Australia
Gene structure, expression and regulation: DNA structure and replication
Dr. Carole Sargent University of Cambridge, UK
Gene structure, expression and regulation: translation and regulation of gene expression
Dr. Carole Sargent University of Cambridge, UK
B cell biology
Prof. Richard Cornall University of Oxford, UK
A brief look at human evolution
Prof. Steve Jones University College London, UK
Medical care for children on the autism spectrum
Dr. Elizabeth Wiesner Yale New Haven Hospital and Yale Medical School, USA
Autism spectrum disorder: psychiatric comorbidities
Dr. Gerrit van Schalkwyk Brown University, USA
Applied behavior analysis: conceptual foundations 1
Dr. Mark J. Palmieri Center for Children with Special Needs, USA
Applied behavior analysis: application elements 2
Dr. Mark J. Palmieri Center for Children with Special Needs, USA
HIV and the immune system
Prof. Quentin Sattentau University of Oxford, UK
Yaws: past and present eradication efforts
Prof. Oriol Mitjà Fight Aids and Infectious Diseases Foundation, Hospital Germans Trias i Pujol, Barcelona,, Spain
Overview of nonclinical safety assessment
Dr. Claudette L. Fuller Merck Research Laboratories, USA
Biological safety testing: supporting medical device combination products
Dr. Christine L. Lanning Merck & Co., Inc., USA
Allergic diseases of the eye
Prof. Constance H. Katelaris Western Sydney University, Australia
The COVID-19 coronavirus outbreak: October 2020 update
Prof. Jonathan Temte University of Wisconsin, USA
The cardiovascular complications of SARS-CoV-2 infection
Prof. Srihari Naidu New York Medical College, USA
Rheumatic diseases and COVID-19
Dr. Zachary Wallace Massachusetts General Hospital and Harvard Medical School, USA
Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers
Dr. Nina Le Bert DUKE-NUS Medical School, Singapore
Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers
Dr. Nina Le Bert DUKE-NUS Medical School, Singapore
Rheumatic diseases and COVID-19
Dr. Zachary Wallace Massachusetts General Hospital and Harvard Medical School, USA
The COVID-19 coronavirus outbreak: October 2020 update
Prof. Jonathan Temte University of Wisconsin, USA
The cardiovascular complications of SARS-CoV-2 infection
Prof. Srihari Naidu New York Medical College, USA
Introduction to the immune system
Prof. Herman Waldmann University of Oxford, UK
Predicting COVID-19 outbreaks by measuring SARS-CoV-2 RNA in sewage sludge
Prof. Jordan Peccia Yale University, USA
Successes and failures with vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA
Medical wearable devices for tracking symptoms of COVID-19
Prof. John Rogers Northwestern University, USA
Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA
The evolutionary origin of SARS-CoV-2
Dr. Feng Gao Duke University Medical Center, USA
Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
Dr. Marietjie Venter National Institute for Communicable Disease, South Africa
Risk of re-emergence of COVID-19 after exit from lockdown
Dr. Leonardo Lopez Barcelona Institute for Global Health, Spain
Hepatitis C virus: discovery, cure and protection
Dr. Matthew Evans Icahn School of Medicine at Mount Sinai, USA
PI 3-kinases and lipid messengers
Prof. Bart Vanhaesebroeck University College London, UK
Antibodies to control or prevent type 1 diabetes
Dr. Robert Hilbrands Brussels Free University, Belgium
Evidence-based practices for children with autism spectrum disorder
Dr. Brian Reichow University of Florida, USA
Understanding and assessing language and communication in children with ASD
Dr. Patricia A. Prelock The University of Vermont, USA
Chronic spontaneous and inducible urticaria
Prof. Marcus Maurer Charité - Universitätsmedizin Berlin, Germany
Outcomes in children born after assisted reproductive technology
Prof. Alastair Sutcliffe UCL GOS Institute of Child Health, UK
Eliminating human rabies deaths: rabies as a disease and a global burden
Prof. Sarah Cleaveland, OBE, FRS University of Glasgow, UK
Eliminating human rabies deaths: targeting the elimination of rabies
Prof. Sarah Cleaveland, OBE, FRS University of Glasgow, UK
Drug delivery to the colon
Dr. Susan Hua University of Newcastle, Australia
Selection bias in studies with unequal allocation
Dr. Olga M. Kuznetsova Merck & Co., Inc, USA
Managing hyperglycaemia in people with DM and CKD: establishing chronic co-pathology
Dr. Peter Winocour Clinical Director, ENHIDE, UK
Managing hyperglycaemia in people with DM and CKD: cardiovascular disease (CVD) involvement
Dr. Peter Winocour Clinical Director, ENHIDE, UK
Predicting COVID-19 outbreaks by measuring SARS-CoV-2 RNA in sewage sludge
Prof. Jordan Peccia Yale University, USA
The evolutionary origin of SARS-CoV-2
Dr. Feng Gao Duke University Medical Center, USA
Medical wearable devices for tracking symptoms of COVID-19
Prof. John Rogers Northwestern University, USA
Risk of re-emergence of COVID-19 after exit from lockdown
Dr. Leonardo Lopez Barcelona Institute for Global Health, Spain
Predicting COVID-19 outbreaks by measuring SARS-CoV-2 RNA in sewage sludge
Prof. Jordan Peccia Yale University, USA
Medical wearable devices for tracking symptoms of COVID-19
Prof. John Rogers Northwestern University, USA
The evolutionary origin of SARS-CoV-2
Dr. Feng Gao Duke University Medical Center, USA
Risk of re-emergence of COVID-19 after exit from lockdown
Dr. Leonardo Lopez Barcelona Institute for Global Health, Spain
Challenges of accelerated vaccine development
Dr. Jakub Simon Director of Clinical Research, Vaccines, Merck Research Laboratories, USA
Convalescent plasma therapy as a treatment for COVID-19
Dr. Manu Shankar-Hari NIHR Clinician Scientist & Consultant in ICM, Guy's and St Thomas' NHS Foundation Trust., UK
Immune responses to viruses
Prof. Paul Klenerman University of Oxford, UK
Remdesivir COVID-19 clinical trial
Prof. Mahesh Parmar University College London, UK
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The development of SARS-CoV-2 vaccines
Prof. Peter Hotez Baylor College of Medicine, USA
Principles of virology
Prof. Vincent Racaniello Columbia University, USA
Nanotechnologies in the fight against coronaviruses
Prof. Sabine Szunerits University of Lille, France
Introduction to the immune system
Prof. Herman Waldmann University of Oxford, UK
Hematopoiesis: the making of an immune system
Prof. Paul J. Fairchild University of Oxford, UK
Regulated cell death mechanisms and their crosstalk with the immune system 1
Dr. Luis Alberto Baena-Lopez University of Oxford, UK
Regulated cell death mechanisms and their crosstalk with the immune system 2
Dr. Luis Alberto Baena-Lopez University of Oxford, UK
The immunology of multiple sclerosis
Dr. Joanne Jones University of Cambridge, UK
MRD driven multiple myeloma treatment: next step forward
Prof. Ola Landgren Memorial Sloan Kettering Cancer Center, USA
Fundamentals of protein chromatography: basic protein purification
Emeritus Prof. Richard R. Burgess University of Wisconsin-Madison, USA
Fundamentals of protein chromatography: protein chromatography
Emeritus Prof. Richard R. Burgess University of Wisconsin-Madison, USA
Mosaicism
Prof. Eamonn Maher University of Cambridge, UK
Darwin's legacy: evolutionary interactions
Prof. Vassiliki Betty Smocovitis University of Florida, USA
Tolerance induction to clotting factors with monoclonal antibodies
Prof. Luís Graça University of Lisbon, Portugal
Schistosomiasis
Prof. Russel Stothard Liverpool School of Tropical Medicine, UK
Hard tissue biology in human health and evolution: craniofacial biology
Prof. Timothy Bromage New York University, USA
Liver and spleen
Emeritus Prof. Kapil S. Satyapal University of KwaZulu-Natal, South Africa
Approaches for elucidating genetic susceptibility to SARS-CoV-2
Dr. Kenneth Baillie University of Edinburgh, UK
Human challenge trials for vaccines against COVID-19
Prof. Peter Smith London School of Hygiene & Tropical Medicine, UK
The immune system response to the SARS-CoV-2 virus: July 2020 update
Prof. Paul Klenerman University of Oxford, UK
The impact of COVID-19 in the elderly and in care homes
Dr. David Strain University of Exeter Medical School, UK
Remdesivir COVID-19 clinical trial
Prof. Mahesh Parmar University College London, UK
The development of SARS-CoV-2 vaccines
Prof. Peter Hotez Baylor College of Medicine, USA
Nanotechnologies in the fight against coronaviruses
Prof. Sabine Szunerits University of Lille, France
Convalescent plasma therapy as a treatment for COVID-19
Dr. Manu Shankar-Hari NIHR Clinician Scientist & Consultant in ICM, Guy's and St Thomas' NHS Foundation Trust., UK
INFβ therapy for COVID-19: the new SNG001 drug
Prof. Stephen Holgate University of Southampton, UK
The immunogenicity problem in antibody therapy
Prof. Herman Waldmann University of Oxford, UK
Successes and failures with vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA
The immune system response to the SARS-CoV-2 virus: an update
Prof. Paul Klenerman University of Oxford, UK
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA
Implementation of adaptive methods in early phase clinical trials
Prof. Gina Petroni University of Virginia, USA
Inorganic nanostructured interfaces for therapeutic delivery
Prof. Tejal Desai University of California, San Francisco, USA
Vaccine delivery
Prof. Sevda Şenel Hacettepe University, Turkey
Intravenous immunoglobulins: clinical evidence
Prof. Shaye Kivity Sheba Medical Center, Israel
Strategies for exiting the lockdown
Prof. David McCoy Queen Mary University of London, UK
INFβ therapy for COVID-19: the new SNG001 drug
Prof. Stephen Holgate University of Southampton, UK
SARS-CoV-2 human monoclonal antibody therapy
Prof. James Crowe Vanderbilt Vaccine Center, USA
The COVID-19 coronavirus outbreak: May 2020 update
Prof. Jonathan Temte University of Wisconsin, USA
Antiviral drugs (non-HIV)
Prof. Megan Shaw Mount Sinai, USA
The type I interferon system and viruses
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA
The immunogenicity problem in antibody therapy
Prof. Herman Waldmann University of Oxford, UK
Antibody engineering: beginnings to bispecifics and beyond
Dr. Ian Wilkinson Absolute Antibody, UK
Phage display for generating monoclonal antibodies
Dr. Andre Frenzel YUMAB GMBH, Germany
Usage of vaccines and therapeutics in public health emergencies 1
Prof. Gary Kobinger Laval University, Canada
The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
COVID-19 epidemiology and potential treatments: follow up interview - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Principles of virology
Prof. Vincent Racaniello Columbia University, USA
Immune responses to viruses
Prof. Paul Klenerman University of Oxford, UK
Fundamentals of HIV biology
Prof. Viviana Simon Icahn School of Medicine at Mount Sinai, USA
Cytomegalovirus biology
Prof. Domenico Tortorella Icahn School of Medicine at Mount Sinai, USA
Binding kinetics in drug discovery
Dr. Rumin Zhang VP of Discovery, Rafael Pharmaceuticals, USA
Subarachnoid hemorrhage (SAH)
Prof. R. Loch Macdonald University of San Francisco, USA
Treating diabetes in the elderly: overcoming challenges
Dr. David Strain University of Exeter Medical School, UK
Ethnic variation in the susceptibility to diabetes
Prof. Jonathan Shaw Baker IDI Heart and Diabetes Institute, Australia
Disorders of gastric function: gastroparesis and functional dyspepsia 1
Dr. Braden Kuo Harvard Medical School, USA
Disorders of gastric function: gastroparesis and functional dyspepsia 2
Dr. Braden Kuo Harvard Medical School, USA
Pediatric stroke: cerebrovascular injury in the developing brain
Prof. Adam Kirton University of Calgary, Canada
Prevention: carotid endarterectomy, angioplasty, and stenting
Prof. Brian Hoh University of Florida, USA
Measles
Prof. Diane E. Griffin Johns Hopkins Bloomberg School of Public Health, USA
Chagas disease
Prof. Peter Hotez Baylor College of Medicine, USA
The immune system response to the SARS-COV-2 virus: an update
Prof. Paul Klenerman University of Oxford, UK
Development of an intranasal vaccine for SARS-CoV-2
Dr. Scot Roberts CSO, Altimmune, USA
Development of PRO-140 (Leronlimab) as a treatment for COVID-19
Dr. Jacob Lalezari Quest Clinical Research, USA
COVID-19 epidemiology and potential treatments: follow up interview
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
COVID-19 epidemiology and potential treatments: follow up interview - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Development of PRO-140 (Leronlimab) as a treatment for COVID-19 - (open access)
Dr. Jacob Lalezari Quest Clinical Research, USA
The impact of genomic architecture and diversity on infectious diseases
Prof. Vincent Chow National University of Singapore, Singapore
Antiviral drugs (non-HIV)
Prof. Megan Shaw Mount Sinai, USA
Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA
The type I interferon system and viruses
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA
HIV cure: harnessing innate and adaptive strategies
Prof. Luis Montaner The Wistar Institute, USA
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The COVID-19 outbreak: an update on the SARS-CoV-2 virus - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV-2 vaccine development - (open access)
Prof. Stanley Plotkin University of Pennsylvania, USA
SARS-COV-2: What we need to know and possible future therapies - (open access)
Prof. Stanley Perlman University of Iowa, USA
SARS-COV-2: What we need to know and possible future therapies - (open access)
Prof. Stanley Perlman University of Iowa, USA
SARS-COV-2 vaccine development: where are we now? - (open access)
Prof. Gary Kobinger Laval University, Canada
The current understanding of the biology of the SARS-COV-2 virus - (open access)
Prof. Peter Palese Mount Sinai School of Medicine, USA
SARS-COV-2 vaccine: current biological targets and considerations - (open access)
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA
The paediatric response to the SARS-COV-2 virus and what we can learn from it - (open access)
Prof. Sallie Permar Duke University Medical School, USA
The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV-2 vaccine development - (open access)
Prof. Stanley Plotkin University of Pennsylvania, USA
The immune system response to the SARS-COV-2 virus - (open access)
Prof. Paul Klenerman University of Oxford, UK
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
Dr. Marietjie Venter NICD, South Africa
Usage of vaccines and therapeutics in public health emergencies 1
Prof. Gary Kobinger Laval University, Canada
Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA
Mitochondrial diseases: an update
Dr. Ayesha Saleem University of Manitoba, Canada
The mast cells: the mastermind cells of the allergic inflammatory reaction
Prof. Adrian Piliponsky University of Washington, USA
Eosinophil functions in allergic diseases: an evolving paradigm
Prof. Lisa A. Spencer University of Colorado School of Medicine, USA
The role of basophils in allergy
Prof. Franco H. Falcone Justus Liebig University Giessen, Germany
An introduction to autism and the autism spectrum
Prof. Fred Volkmar Yale University School of Medicine, USA
The epidemiology of autism spectrum disorders: history and current estimates
Prof. Eric Fombonne Oregon Health and Science University, USA
The epidemiology of autism spectrum disorders: time trends and world perspectives
Prof. Eric Fombonne Oregon Health and Science University, USA
Assessment and diagnosis of individuals with Autism Spectrum Disorder (ASD)
Dr. Julie M. Wolf Yale Child Study Center, USA
Plant-soil feedbacks
Dr. Ciska Veen Netherlands Institute of Ecology, Netherlands
Cholesterol oxidation between health and disease
Prof. Giuseppe Poli University of Torino, Italy
Tropical snakebite
Prof. Robert Harrison Liverpool School of Tropical Medicine, UK
Innovative and effective subject randomization methods
Prof. Wenle Zhao Medical University of South Carolina, USA
The COVID-19 outbreak: an update on the SARS-CoV-2 virus
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The immune system response to the SARS-COV-2 virus
Prof. Paul Klenerman University of Oxford, UK
The current understanding of the biology of the SARS-COV-2 virus
Prof. Peter Palese Mount Sinai School of Medicine, USA
The paediatric response to the SARS-COV-2 virus and what we can learn from it
Prof. Sallie Permar Duke University Medical School, USA
The COVID-19 coronavirus outbreak: a follow-up interview
Prof. Jonathan Temte University of Wisconsin, USA
The COVID-19 coronavirus outbreak: a current view
Prof. Jonathan Temte University of Wisconsin, USA
The immune system response to the SARS-COV-2 virus
Prof. Paul Klenerman University of Oxford, UK
The immune system: an overview - innate immunity
Prof. Shiv Pillai Harvard Medical School, USA
The immune system: an overview - adaptive immunity
Prof. Shiv Pillai Harvard Medical School, USA
The complement system - an introduction for undergraduates
Prof. Michael Holers University of Colorado School of Medicine, USA
Vaccine delivery
Prof. Sevda Şenel Hacettepe University, Turkey
Biodefense challenges
Dr. David Franz US Army (Retired) and Kansas State University., USA
History of vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA
Successes and failures with vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA
The COVID-19 outbreak: an update on the SARS-CoV-2 virus - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Vaccine delivery
Prof. Sevda Şenel Hacettepe University, Turkey
The COVID-19 coronavirus outbreak: a current view - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Vaccine adjuvants 1
Dr. Derek O'Hagan GSK Vaccine Research, USA